|
Article Excerpt Podium presentation, entitled "Safety, tolerability and pharmacokinetics of AEOL 10150 in ALS," to be presented by Robert G. Miller, MD on December 8, 2005
SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Aeolus Pharmaceuticals, Inc. (BULLETIN BOARD: AOLS.OB) , a developer of a new class of disease-modifying compounds with potent activity in pre-clinical models of central nervous system diseases and oncology, announced today that results from its Phase I single dose study of AEOL 10150 in patients with amyotrophic lateral sclerosis will be presented today by Dr. Robert G. Miller, Professor, UCSF Department of Neurology, California Pacific Medical Center, at the 16th International Symposium on ALS/MND, Dublin, Republic of Ireland. Amyotrophic lateral sclerosis is also referred to as ALS or Lou Gehrig's disease.
The presentation, entitled "Safety, tolerability and pharmacokinetics of AEOL 10150 in ALS" includes as co-authors the Principal Investigators from the single-dose study (Drs. Miller, Cudkowicz, Gordon, Heiman-Patterson, Maragakis, Mitsumoto and Shefner) all of whom specialize in the clinical treatment of ALS.
As noted...
|
|

More articles from PR Newswire
BellSouth Announces Toys for Tots Drive in Atlanta., December 08, 2005 Alternative Energy Expert and Author Richard Jablin Delivers Keynote A..., December 08, 2005 Southern California Business Owners Forecast Ongoing Economic Expansio..., December 08, 2005 Jeff Gordon early favorite to win Daytona 500., December 08, 2005 Recruitmax Named to Forbes.com Best of The Web Directory., December 08, 2005
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|